Clinical Trials Directory

Trials / Conditions / Philadelphia-Positive ALL

Philadelphia-Positive ALL

7 registered clinical trials studyying Philadelphia-Positive ALL — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
NCT06287528
Memorial Sloan Kettering Cancer CenterPhase 1
RecruitingA Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patient
NCT06220487
Nanfang Hospital, Southern Medical UniversityPhase 2
Not Yet RecruitingTreatment Protocol for Newky Diagnosed Adult Ph Positive ALL
NCT06175702
PETHEMA Foundation—
Not Yet RecruitingA Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
NCT05931757
The First Affiliated Hospital of Soochow UniversityPhase 2
UnknownA Study of Olverembatinib in the Treatment of Ph+ ALL
NCT05466175
Chen SuningPhase 2
Active Not RecruitingSequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+
NCT04722848
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 3
Active Not RecruitingPonatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 2